Pulmonary alveolar proteinosis, N Engl J Med, vol.258, pp.1123-1165, 1958. ,
,
Pulmonary alveolar proteinosis, Nat Rev Dis Primers, vol.5, p.16, 2019. ,
Pulmonary alveolar proteinosis, Eur Respir Rev, vol.20, pp.98-107, 2011. ,
Pulmonary alveolar proteinosis: new insights from a single-center cohort of 70 patients, Respir Med, vol.105, pp.1908-1924, 2011. ,
, Rev Mal Respir, vol.19, pp.166-82, 2002.
,
Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan, Am J Respir Crit Care Med, vol.177, pp.752-62, 2008. ,
Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review, Mayo Clin Proc, vol.62, pp.499-518, 1987. ,
Pulmonary alveolar proteinosis: progress in the first 44 years, Am J Respir Crit Care Med, vol.166, pp.215-250, 2002. ,
Quantitative Lipidomics in Pulmonary Alveolar Proteinosis, Am J Respir Crit Care Med, vol.200, pp.881-888, 2019. ,
Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis, Nat Commun, vol.9, p.3127, 2018. ,
,
Targeting cholesterol homeostasis in lung diseases, Sci Rep, vol.7, p.10211, 2017. ,
,
ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis, J Lipid Res, vol.48, pp.2762-2770, 2007. ,
Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology, Proc Natl Acad Sci U S A, vol.91, pp.5592-5598, 1994. ,
,
, GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through, PU.1. Immunity, vol.15, pp.557-67, 2001.
,
PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor, Am J Physiol Lung Cell Mol Physiol, vol.285, pp.1132-1138, 2003. ,
Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis, N Engl J Med, vol.361, pp.2679-81, 2009. ,
GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis, N Engl J Med, vol.356, pp.567-79, 2007. ,
,
Pulmonary alveolar proteinosis, Rev Mal Respir, vol.31, pp.975-91, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01085907
Fleischner Society: glossary of terms for thoracic imaging, Radiology, vol.246, pp.697-722, 2008. ,
Crazy-paving" pattern at thin-section CT of the lungs: radiologic-pathologic overview, Radiographics, vol.23, pp.1509-1528, 2003. ,
,
High-affinity autoantibodies specifically eliminate granulocytemacrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis, Blood, vol.103, pp.1089-98, 2004. ,
,
Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis, J Immunol Methods, vol.402, pp.57-70, 2014. ,
Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis, Clin Immunol, vol.105, pp.342-50, 2002. ,
Serological diagnosis of idiopathic pulmonary alveolar proteinosis, Am J Respir Crit Care Med, vol.162, pp.658-62, 2000. ,
,
, Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects, Blood, vol.113, pp.2547-56, 2009.
An open-label trial of rituximab therapy in pulmonary alveolar proteinosis, Eur Respir J, vol.38, pp.1361-1368, 2011. ,
Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis, Thorax, vol.61, pp.528-562, 2006. ,
Pulmonary alveolar proteinosis: high-resolution CT, chest radiographic, and functional correlations, Chest, vol.111, pp.989-95, 1997. ,
Inhaled GM-CSF for Pulmonary Alveolar Proteinosis, N Engl J Med, vol.381, pp.923-955, 2019. ,
Clinical features of autoimmune pulmonary alveolar proteinosis from a large international patient cohort: baseline data from the IMPALA trial, Eur Respir J, p.5328, 2019. ,
Opportunistic infections in patients with pulmonary alveolar proteinosis, J Infect, vol.65, pp.173-182, 2012. ,
Osaka Respiratory Diseases Symposia. Pulmonary Fibrosis on High-Resolution CT of Patients With Pulmonary Alveolar Proteinosis, AJR Am J Roentgenol, vol.207, pp.544-51, 2016. ,
,
Relationship between diffuse pulmonary fibrosis, alveolar proteinosis, and granulocyte-macrophage colony stimulating factor autoantibodies, Respir Care, vol.56, pp.1608-1618, 2011. ,
Pulmonary alveolar proteinosis revealing a telomerase disease, Am J Respir Crit Care Med, vol.188, pp.402-406, 2013. ,
Quantitative assessment of Pulmonary Alveolar Proteinosis (PAP) with ultradose CT and correlation with Pulmonary Function Tests (PFTs), PLoS One, vol.12, p.172958, 2017. ,
,
A Semiquantitative Computed Tomographic Grading System for Evaluating Therapeutic Response in Pulmonary Alveolar Proteinosis, Ann Am Thorac Soc, vol.14, pp.1403-1414, 2017. ,
Quantitative analysis of longitudinal response to aerosolized granulocyte-macrophage colony-stimulating factor in two adolescents with autoimmune pulmonary alveolar proteinosis, Chest, vol.135, pp.842-850, 2009. ,
,
,
Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis, Am J Respir Crit Care Med, vol.181, pp.1345-54, 2010. ,
Shaping the future of an ultra-rare disease: unmet needs in the diagnosis and treatment of pulmonary alveolar proteinosis, Curr Opin Pulm Med, vol.25, pp.450-458, 2019. ,
Pulmonary alveolar proteinosis. Diagnostic technics and observations, N Engl J Med, vol.268, pp.165-71, 1963. ,
Intrathoracic pressure, pulmonary vascular pressures and gas exchange during pulmonary lavage, Anesthesiology, vol.33, pp.401-406, 1970. ,
Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis, Thorax, vol.55, pp.67-77, 2000. ,
,
Groupe d''Endoscopie Thoracique de Langue. Efficacy of Whole-Lung Lavage in Pulmonary Alveolar Proteinosis: A Multicenter International Study of GELF, Respiration, vol.93, pp.198-206, 2017. ,
,
A Global Survey on Whole Lung Lavage in Pulmonary Alveolar Proteinosis, Chest, vol.150, pp.251-254, 2016. ,
Lipids in the lungs: radiologic-pathologic correlation, J Can Assoc Radiol, vol.21, pp.2-15, 1970. ,
Whole-lung lavage for pulmonary alveolar proteinosis, Chest, vol.136, pp.1678-81, 2009. ,
Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocytemacrophage colony-stimulating factor: a meta-analyses, Eur Respir J, vol.19, pp.1503-1509, 2009. ,
Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis, Respir Res, vol.13, p.46, 2012. ,
Rituximab for auto-immune alveolar proteinosis, a real life cohort study, Respir Res, vol.19, p.74, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01791591
A plasmapheresis protocol for refractory pulmonary alveolar proteinosis, Lung, vol.193, pp.209-220, 2015. ,
Plasmapheresis failure in the treatment of auto-immune pulmonary alveolar proteinosis, Rev Mal Respir, vol.34, pp.240-243, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01526427
, Am J Respir Crit Care Med, vol.167, 1036.
Plasmapheresis for treatment of pulmonary alveolar proteinosis, Eur Respir J, vol.33, pp.1220-1222, 2009. ,
, Whole lung lavage combined with
, Granulocyte-macrophage colony stimulating factor inhalation for an adult case of refractory pulmonary alveolar proteinosis, BMC Pulm Med, vol.14, p.87, 2014.
Recurrent alveolar proteinosis following double lung transplantation, Chest, vol.111, pp.1457-1465, 1997. ,
Cytopathology of pulmonary alveolar proteinosis complicating lung transplantation, J Heart Lung Transplant, vol.23, pp.135-143, 2004. ,
Alveolar lipoproteinosis in lung allograft recipients, Hum Pathol, vol.28, pp.1383-1389, 1997. ,
,
Secondary pulmonary alveolar proteinosis predominant in the transplanted lung in patients with idiopathic interstitial pneumonia: an autopsy case, J Thorac Dis, vol.10, pp.351-355, 2018. ,
,
Pulmonary alveolar proteinosis: a rare pulmonary toxicity of sirolimus, Transpl Int, vol.20, pp.291-297, 2007. ,
, I. T. Investigators. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases, vol.381, pp.1718-1745, 2019.